中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

经内镜逆行胰胆管造影胆道金属支架置入治疗不可切除肝外胆道恶性梗阻的效果观察

徐刚

方长英, 朱传卫, 张青松, 何勇勇. 原发性肝癌组织中长链非编码RNA外泌体复合物7的表达及临床意义[J]. 临床肝胆病杂志, 2019, 35(1): 123-126. DOI: 10.3969/j.issn.1001-5256.2019.01.023.
引用本文: 方长英, 朱传卫, 张青松, 何勇勇. 原发性肝癌组织中长链非编码RNA外泌体复合物7的表达及临床意义[J]. 临床肝胆病杂志, 2019, 35(1): 123-126. DOI: 10.3969/j.issn.1001-5256.2019.01.023.
Fang ZhangYing, Zhu ChuanWei, Zhang QingSong, He YongYong. Expression and clinical significance of long non-coding RNA exocyst complex component 7 in hepatocellular carcinoma[J]. J Clin Hepatol, 2019, 35(1): 123-126. DOI: 10.3969/j.issn.1001-5256.2019.01.023.
Citation: Fang ZhangYing, Zhu ChuanWei, Zhang QingSong, He YongYong. Expression and clinical significance of long non-coding RNA exocyst complex component 7 in hepatocellular carcinoma[J]. J Clin Hepatol, 2019, 35(1): 123-126. DOI: 10.3969/j.issn.1001-5256.2019.01.023.

经内镜逆行胰胆管造影胆道金属支架置入治疗不可切除肝外胆道恶性梗阻的效果观察

DOI: 10.3969/j.issn.1001-5256.2018.02.023
详细信息
  • 中图分类号: R735

Clinical effect of biliary metal stent implantation via endoscopic retrograde cholangiopancreatography in treatment of unresectable malignant extrahepatic biliary obstruction

  • 摘要:

    目的探讨经内镜逆行胰胆管造影(ERCP)胆道金属支架置入对于肝外胆道恶性梗阻的临床疗效及安全性。方法收集2010年1月-2015年12月郑州大学第二附属医院收治的不可切除性肝外胆道恶性梗阻患者40例。根据手术方法不同分为经皮经肝胆管穿刺引流术(PTCD)组和ERCP组各20例。观察2组患者支架通畅期和生存期、术后临床疗效、术后并发症发生情况、术后住院时间等指标。计量资料组间比较采用t检验;计数资料组间比较采用χ2检验或校正的χ2检验。2组支架通畅期和生存期的比较采用Kaplan-Meier法对数秩检验。结果 ERCP组患者的支架通畅期[(225.6±52.5)d vs(156.3±44.5)d]、生存期[(335.6±42.5)d vs(225.5±42.5)d]较PTCD组均明显延长(t值分别为11.45、10.46,P值均<0.05)。ERCP组患者术后发生腹痛(7例)少于PTCD组(10例),差异有统计学意义(35.0%vs 50.0%,χ2=9.45,P<0.05)。ERCP组患者术后严重并发症发生率显著低于PTCD组(10.0%vs 30.0%,χ2=7.49,P...

     

  • [1]CASTRO FA, KOSHIOL J, HSING AW, et al.Biliary tract cancer incidence in the United States-demographic and temporal variations by anatomic site[J].Int J Cancer, 2013, 133 (7) :1664-1671.
    [2]BLECHACZ B, KOMUTA M, ROSKAMS T, et al.Clinical diagnosis and staging of cholangiocarcinoma[J].Nat Rev Gastroenterol Hepatol, 2011, 8 (9) :512-522.
    [3]DEOLIVEIRA ML, SCHULICK RD, NIMURA Y, et al.New staging system and a registry for perihilar cholangiocarcinoma[J].Hepatology, 2011, 53 (4) :1363-1371.
    [4]SIEGEL R, MA J, ZOU Z, et al.Cancer statistics, 2014[J].CA Cancer J Clin, 2014, 64 (1) :9-29.
    [5]MOHAMADNEJAD M, DEWITT JM, SHERMAN S, et al.Role of EUS for preoperative evaluation of cholangiocarcinoma:a large single-center experience[J].Gastrointest Endosc, 2011, 73 (1) :71-78.
    [6]TELLEZ-AVILA FI, BERNAL-MENDEZ AR, GUERREROVAZQUEZ CG, et al.Diagnostic yield of EUS-guided tissue acquisition as a first-line approach in patients with suspected hilar cholangiocarcinoma[J].Am J Gastroenterol, 2014, 109 (8) :1294-1296.
    [7]WEILERT F, BHAT YM, BINMOELLER KF, et al.EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction:results of a prospective, single-blind, comparative study[J].Gastrointest Endosc, 2014, 80 (1) :97-104.
    [8]EL CHAFIC AH, DEWITT J, LEBLANC JK, et al.Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients[J].Endoscopy, 2013, 45 (11) :883-889.
    [9]TUMMALA P, MUNIGALA S, ELOUBEIDI MA, et al.Patients with obstructive jaundice and biliary stricture±mass lesion on imaging:prevalence of malignancy and potential role of EUS-FNA[J].J Clin Gastroenterol, 2013, 47 (6) :532-537.
    [10]KHASHAB MA, FOCKENS P, AL-HADDAD MA.Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos) [J].Gastrointest Endosc, 2012, 76 (5) :1024-1033.
    [11]CAPPELL MS, KILLEEN TC, JURY R.Common bile duct carcinoid mimicking the clinical, EUS, and ERCP findings of cholangiocarcinoma:a rare but potentially curable cause of obstructive jaundice[J].Clin Gastroenterol Hepatol, 2011, 9 (11) :e112-e113.
    [12]LEVY MJ, HEIMBACH JK, GORES GJ.Endoscopic ultrasound staging of cholangiocarcinoma[J].Curr Opin Gastroenterol, 2012, 28 (3) :244-252.
    [13]ANNUNZIATA S, CALDARELLA C, PIZZUTO DA, et al.Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma:a meta-analysis[J].Biomed Res Int, 2014, 2014:247693.
    [14]PARK MS, LEE SM.Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer[J].Anticancer Res, 2014, 34 (5) :2551-2554.
    [15]ITO Y, KENMOCHI T, EGAWA T, et al.Clinicopathological features of early distal cholangiocarcinoma[J].Hepatogastroenterology, 2013, 60 (124) :673-677.
  • 期刊类型引用(11)

    1. 朱惠刚,刘东升,贾楷桥. 腹腔镜下精准肝切除术与常规腹腔镜肝肿瘤切除术治疗原发性肝癌的效果及安全性. 中西医结合肝病杂志. 2022(07): 648-650 . 百度学术
    2. 邓明,邓芳,陈志坚,周福生. 连翘苷对胃癌细胞AGS增殖、迁移和侵袭的抑制作用. 中成药. 2022(09): 3009-3012 . 百度学术
    3. 赵金磊,季春勇,石伟,罗红杰,季予江,刘东亮. 长链非编码RNA MIAT在肝细胞癌组织中的表达及临床意义. 临床肿瘤学杂志. 2021(03): 217-221 . 百度学术
    4. 侯亚萍,张小晶,李婷. 原发性肝癌患者LncRNA-MEG3表达与临床病理特征及预后的关系. 肝脏. 2021(07): 757-760 . 百度学术
    5. 陈绪林,姜宇,赵艳,李彩华,高逸之. 原发性肝癌组织中miR-557的表达及其与预后的关系. 国际消化病杂志. 2021(04): 313-316 . 百度学术
    6. 杜小梅,吕建宁,李雯. 长链非编码RNA EXOC7在非小细胞肺癌中的表达及临床意义分析. 临床肺科杂志. 2020(04): 592-595 . 百度学术
    7. 林洁,黄炳臣,王娟,黄云美,黄小英. 肝癌患者组织及血清微小RNA-24和微小RNA-629的表达水平及其临床意义. 广西医学. 2020(14): 1775-1778 . 百度学术
    8. 梅洪亮,黄致远,胡逸林,江艳,陈敏,卢绮萍,刘志苏. 长链非编码RNA KCNQ1重叠转录物1在肝细胞癌迁移及增殖和侵袭中的作用与机制研究. 中华消化外科杂志. 2020(10): 1083-1090 . 百度学术
    9. 杨书才,张莉,刘利平,邓唯杰,周杰,刘慧,张鲍虎,金涛. 缺氧诱导因子2α对肝细胞癌化疗耐药性的影响. 中国临床药理学与治疗学. 2019(06): 630-636 . 百度学术
    10. 钟蓝海,马丹丹,张智勇,张翌,蔡逊. 基于数据挖掘分析FAM134B在肝癌中的表达及其与预后的关系. 临床肝胆病杂志. 2019(11): 2508-2512 . 本站查看
    11. 唐丽,唐华,孙强. FOXM1、FOXO3a在肝癌中的表达及其临床意义. 临床医学研究与实践. 2019(36): 24-26 . 百度学术

    其他类型引用(3)

  • 加载中
计量
  • 文章访问数:  2151
  • HTML全文浏览量:  45
  • PDF下载量:  405
  • 被引次数: 14
出版历程
  • 出版日期:  2018-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回